http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6162426-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate | 1997-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94eaa40fe97d2830618786906a786626 |
| publicationDate | 2000-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6162426-A |
| titleOfInvention | Use of G-CSF to enhance the immune system in neonates |
| abstract | The invention relates to the use of Granulocyte Colony Stimulating Factor (G-CSF) to enhance the immune system in neonates by increasing the Absolute Neutrophil Count and/or increasing the Fc gamma receptor density on the surface of neutrophils in neonates. More particularly, the invention relates to the use of G-CSF to enhance neutrophil production and/or Fc gamma receptor density in very Low Birth Weight (VLBW) neonates, pre-eclamptic neutropenic neonates, and septic-neutropenic neonates. The invention also includes the use of G-CSF in association with IUGG to enhance opsonziation of infectious organisms either by prophylaxis or as a therapeutic intervention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010011735-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11273202-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10138283-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021008042-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3103880-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3225248-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2805964-A1 |
| priorityDate | 1997-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.